This ResMed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Ellington Financial Inc.
Leidos Holdings, Inc.
ResMed Inc.
Simulations Plus, Inc.

Ellington Financial Inc.

EFC

0.00

Leidos Holdings, Inc.

LDOS

0.00

ResMed Inc.

RMD

0.00

Simulations Plus, Inc.

SLP

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • BTIG analyst Douglas Harter downgraded Ellington Financial Inc (NYSE:EFC) from Buy to Neutral. Ellington Financial shares closed at $13.67 on Tuesday. See how other analysts view this stock.
  • B of A Securities analyst Mariana Perez downgraded Leidos Holdings, Inc. (NYSE:LDOS) from Buy to Neutral and cut the price target from $200 to $125. Leidos shares closed at $113.58 on Tuesday. See how other analysts view this stock.
  • Goldman Sachs analyst Adrien Duverger downgraded Ermenegildo Zegna N.V. (NYSE: ZGN) from Buy to Neutral and raised the price target from $13.3 to $14. Ermenegildo Zegna shares closed at $14.49 on Tuesday. See how other analysts view this stock.
  • William Blair analyst Max Smock downgraded Simulations Plus, Inc. (NASDAQ:SLP) from Outperform to Market Perform. Simulations Plus shares closed at $18.24 on Tuesday. See how other analysts view this stock.
  • Morgan Stanley analyst David Bailey downgraded ResMed Inc. (NYSE:RMD) from Overweight to Equal-Weight and lowered the price target from $286 to $230. ResMed shares closed at $193.94 on Tuesday. See how other analysts view this stock.

Considering buying EFC stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.